My Cancer Circle
My Cancer Circle is a free, private community to help support caregivers of people facing cancer
Founded in 1944, CancerCare is the leading national organization providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer. Our comprehensive services include counseling and support groups over the phone, online and in-person, educational workshops, publications and financial and co-payment assistance. All CancerCare services are provided by oncology social workers and world-leading cancer experts. To learn more, visit www.cancercare.org or call 800-813-HOPE (4673).
About Lotsa Helping Hands
Lotsa Helping Hands was created to support family caregivers and volunteers by empowering their circles of community that are eager to help those in need.
Lotsa Helping Hands powers online caring communities that help restore health and balance to caregivers’ lives.The service brings together caregivers and volunteers through online communities that help organize daily life during times of medical crisis or caregiver exhaustion in neighborhoods and communities worldwide. Caregivers benefit from the gifts of much-needed real-life help, emotional support and peace of mind, while volunteers receive joy from giving back to those in need. We provide regular support to Members and Coordinators of My Cancer Circle communities to ensure that everyone has what they need to get the most out of their experience. Lotsa Helping Hands is not an affiliate of Boehringer Ingelheim Pharmaceuticals, Inc.
About Boehringer Ingelheim
The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.
Building on scientific expertise and excellence in the fields of pulmonary and cardiovascular medicine, metabolic disease, neurology, virology and immunology, Boehringer Ingelheim has embarked on a major research program to develop innovative cancer drugs. Working in close collaboration with the international scientific community and a number of the world's leading cancer centers, Boehringer Ingelheim is committed to discovering and developing novel cancer treatments. This commitment is underpinned by using advances in science to develop a range of targeted therapies in areas of medical need. Boehringer Ingelheim's oncology pipeline continues to evolve and demonstrates the company's continued commitment to the disease area.